Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins
- 1 January 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 339 (3) , 915-922
- https://doi.org/10.1016/j.bbrc.2005.11.095
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 bindingNature Cell Biology, 2005
- Nrf2 signaling in coordinated activation of antioxidant gene expressionFree Radical Biology & Medicine, 2004
- Agonist-specific Transactivation of Phosphoinositide 3-Kinase Signaling Pathway Mediated by the Dopamine D2 ReceptorJournal of Biological Chemistry, 2003
- PI3 kinase enhancer–Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosisNature Neuroscience, 2003
- Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase BJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2003
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Selegiline and Desmethylselegiline Stimulate NGF, BDNF, and GDNF Synthesis in Cultured Mouse AstrocytesBiochemical and Biophysical Research Communications, 2000
- The TrkB-Shc Site Signals Neuronal Survival and Local Axon Growth via MEK and PI3-KinaseNeuron, 2000
- The effect of a subchronic post-lesion treatment with (?)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- (−)‐Deprenyl Protects Human Dopaminergic Neuroblastoma SH‐SY5Y Cells from Apoptosis Induced by Peroxynitrite and Nitric OxideJournal of Neurochemistry, 1998